Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow morning. Here’s what investors should know.

GE HealthCare met analysts’ revenue expectations last quarter, reporting revenues of $4.86 billion, flat year on year. It was a mixed quarter for the company, with a narrow beat of analysts’ full-year EPS guidance estimates but organic revenue in line with analysts’ estimates.

Is GE HealthCare a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting GE HealthCare’s revenue to grow 2.2% year on year to $5.32 billion, slowing from the 5.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.26 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. GE HealthCare has missed Wall Street’s revenue estimates six times over the last two years.

Looking at GE HealthCare’s peers in the healthcare equipment and supplies segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Hologic posted flat year-on-year revenue, meeting analysts’ expectations, and Intuitive Surgical reported revenues up 25.2%, topping estimates by 6.5%. Hologic traded down 10.1% following the results while Intuitive Surgical was also down 4%.

Read our full analysis of Hologic’s results here and Intuitive Surgical’s results here.

Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. GE HealthCare is up 3.4% during the same time and is heading into earnings with an average analyst price target of $96.51 (compared to the current share price of $87.03).

Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.